| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8215880 | International Journal of Radiation Oncology*Biology*Physics | 2015 | 9 Pages |
Abstract
Our data suggest that HPV/p16 signature determines prognosis. HPV+/p16+Â patients had the best prognosis, and HPVâ/p16+Â and HPVâ/p16â patients showed the worst outcome and therefore require therapy optimization, particularly given that LC is the most important factor for OS.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Sabine MD, Grit MSc, Martine MD, Frank MD, Sebastin Severa, Elena-Sophie MD, Nicolas MD, Marcus J. MD, Frederik MD, Magnus MD, Miriam MD,